We assume that the presence of EMV surface marker CD90 in the CM derived from RR-MS patients and healthy donors hPDLSCs may induce the production of IL-10 since the positive regulatory role of CD90 in IL-10 production has been already reported43. The gene discussed is IL10; the disease is myeloid sarcoma.